NORML Pushes Federal Advocacy Despite State-Level Wins

The National Organization for the Reform of Marijuana Laws remains focused on federal policy reform even as cannabis becomes increasingly normalized across state markets, according to the advocacy group's leadership.

Christopher Cano, a senior official at NORML, argues that widespread state-level legalization has created a false sense of completion in the cannabis reform movement. The organization now confronts a strategic challenge: maintaining momentum when millions of Americans already have legal access.

"Cannabis feels normal in 2026," Cano said. "But the fight isn't over."

The disconnect between state progress and federal prohibition creates ongoing complications for the $33 billion U.S. cannabis industry. Banking restrictions, tax burdens under IRS code 280E, and interstate commerce barriers remain in place despite 24 states operating adult-use markets.

The Federal Stalemate

NORML's current advocacy priorities center on federal rescheduling and the SAFER Banking Act, which has stalled in Congress despite bipartisan support in previous sessions. The organization reports that while state-level victories generate headlines, federal reform requires sustained pressure on lawmakers who represent districts without legal cannabis.

The numbers tell the story: roughly 55% of Americans now live in states with legal adult-use cannabis, yet federal employees, military personnel, and residents of prohibition states face criminal penalties for possession. NORML estimates that approximately 350,000 Americans were arrested for cannabis-related offenses in 2024, the most recent year with complete FBI data.

Cano emphasized that normalization in legal states can actually undermine federal reform efforts. Voters in California or Colorado may deprioritize cannabis policy when their local access remains unaffected by Washington gridlock.

Industry Response

Cannabis trade associations have echoed NORML's concerns about complacency. The National Cannabis Industry Association and U.S. Cannabis Council both maintain active federal lobbying operations, though their focus skews toward business regulations rather than criminal justice reform.

Market watchers note that federal prohibition continues to depress cannabis company valuations compared to other consumer packaged goods sectors. Multi-state operators face effective tax rates exceeding 70% due to 280E restrictions, limiting their ability to compete with illicit market operators.

Several MSOs have publicly stated they would expand operations significantly if federal banking access improved. Curaleaf and Trulieve executives told investors in recent earnings calls that current capital constraints limit store openings and acquisition activity.

What's Next

NORML plans to intensify grassroots organizing in prohibition states and swing districts during the 2026 election cycle. The organization is recruiting volunteers to lobby congressional offices and coordinate with state-level reform groups.

The advocacy group also aims to reframe cannabis reform as an economic issue rather than purely a social justice cause. Cano suggested that job creation and tax revenue arguments resonate more effectively with moderate lawmakers than criminal justice messaging alone.

Federal reform prospects remain uncertain heading into the next congressional session. While public opinion polls consistently show 70% support for legalization, Capitol Hill has yet to advance comprehensive reform legislation through both chambers.

NORML argues that sustained advocacy pressure—not just state-level victories—will ultimately force federal action. The organization continues to position itself as the primary voice for consumer-focused reform, distinct from industry lobbying groups.

This article is based on original reporting by hightimes.com.